Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma	Recruiting	Phase 3	2026-10-02		NCT07509099

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ji Dongmei	2

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fudan University Shanghai Cancer Center	Shanghai	China	85
Fudan University Shanghai Cancer Center	Shanghai	China	257

Clinical trials